Graney & King’s GSK GSK Stock Holding History

Graney & King’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$136K	Buy	2,465 +21	+0.9%	+$1.14K	0.07%	83
2025 Q4	$120K	Buy	2,444 +22	+0.9%	+$1.03K	0.07%	85
2025 Q3	$105K	Buy	2,422 +125	+5%	+$4.88K	0.07%	87
2025 Q2	$88.2K	Buy	2,297 +27	+1%	+$1.03K	0.06%	92
2025 Q1	$88K	Buy	2,270 +21	+0.9%	+$769	0.07%	85
2024 Q4	$76K	Buy	+2,249	New	+$81K	0.06%	95

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Graney & King's GSK Position: Q1 2026 in Review

Graney & King increased its GSK (GSK) stake by 0.86% in Q1 2026, buying an estimated $1.14K and bringing the position to 2,465 shares worth $136K. The position accounts for 0.07% of the portfolio, ranked #83.

Graney & King first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Graney & King held 2,465 shares of GSK worth $136K as of Q1 2026.
Graney & King bought 21 GSK shares in Q1 2026, an estimated $1.14K.
GSK made up 0.07% of Graney & King's portfolio in Q1 2026, its #83 holding.
Graney & King first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.